• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Casi Pharmaceuticals Inc (NQ: CASI )

    6.080 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EDT, Sep 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 6.080
    Bid (Size) 6.080 (10)
    Ask (Size) 7.440 (1)
    Prev. Close 6.080
    Today's Range 6.080 - 6.080
    52wk Range 1.957 - 8.480
    Shares Outstanding 13,457,625
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024
    CASI stock results show that CASI Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    3 Promising Biotech Stocks You Can Pick Up for Less Than $10
    Healthcare innovations are big business. That said, biotech stocks under $10 may offer a higher ceiling thanks to their low price. 
    Via InvestorPlace

    Performance

    YTD
    -15.79%
    -15.79%
    1 Month
    -7.95%
    -7.95%
    3 Month
    +60.00%
    +60.00%
    6 Month
    +103.34%
    +103.34%
    1 Year
    +204.00%
    +204.00%

    More News

    Read More
    Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary
    Via Talk Markets
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Recap: CASI Pharmaceuticals Q4 Earnings
    Via Benzinga
    CASI Pharmaceuticals: Q1 Earnings Insights
    Via Benzinga
    CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
    Via Talk Markets
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
    Via Talk Markets
    Week In Review: Novartis In $1 Billion Deal For DTx Pharma
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.